CEMI Financial Facts

Net product sales: 2.5M
Basic net income per share: -0.19
See Full Income Statement

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 22.68M
Accounts payable and accrued liabilities: 2.59M
See Full Balance Sheet

Chembio Diagn (CEMI) Earnings

  |   Expand Research on CEMI
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -17.1% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/9/23 Q123 N/AN/A N/A N/AN/A N/A N/A N/A
3/27/23 Q422 N/A-$0.22 N/A N/A$6.5M N/A N/A N/A
3/20/23 Q422 N/A-$0.22 N/A N/A$6.5M N/A N/A N/A
3/9/23 Q422 N/A-$0.22 N/A N/A$6.5M N/A N/A N/A
11/3/22 Q322 -$0.24-$0.19 -$0.05$12.06M$8.5M N/A Details
8/4/22 Q222 N/A-$0.19 N/A N/A$8.5M N/A N/A N/A
11/10/16 Q315 -$0.19-$0.17 -$0.02$3.75M$3.76M N/A Details
8/11/16 Q215 -$0.86N/A N/A $3.27M$6.72M N/A Details